Blood Glucose Monitoring System Market Size, Share, Growth Report 2030

Blood Glucose Monitoring System Market

Blood Glucose Monitoring System Market By Product (Self-Monitoring and Continuous Glucose Monitoring Devices), By Testing Site (Fingertip Testing and Alternate Site Testing), By Indication (Type-I Diabetes, Type-II Diabetes, and Others), By End-User (Hospitals, Clinics, and Homecare), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Category: Medical Device Report Format : PDF Pages: 205 Report Code: ZMR-3435 Published Date: Jun-2022 Status : Published

The global blood glucose monitoring system market size was at a net worth of $14.79 Billion in 2021 and is projected to grow at a CAGR of 10.12% between 2022-2028 and reach a market value of $31.5 Billion during the forecast period.

Blood Glucose Monitoring System Market

Blood Glucose Monitoring System Market: Industry Prospective

The global blood glucose monitoring system market size was at a net worth of $14.79 Billion in 2021 and is projected to grow at a CAGR of 10.12% between 2022-2028 and reach a market value of $31.5 Billion during the forecast period. The report analyzes the blood glucose monitoring system's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the global blood glucose monitoring system market.

Blood Glucose Monitoring System Market: Overview

A blood glucose monitoring system also known as BGM is an effective tool used for monitoring blood sugar levels, especially for diabetic patients. Blood glucose monitoring systems have helped patients become self-reliant and take control of their medical health. BGM systems track high or low glucose levels and encourage patients to take relevant medication or treatment.

BGM systems work by understanding the resistance to an electric current sent through a blood-stained test strip. Or by inserting a sensor under the patient's skin that reads the glucose level between cell fluids.

The type of blood glucose monitoring system to be used depends on the requirements of the patient. Multiple options for BGM devices are present in the market catering to different medical needs.

The global blood glucose monitoring system is witnessing a surge in its global market value and is projected to touch milestones during the forecast period.

Blood Glucose Monitoring System Market: Growth Drivers

The increasing population of diabetic patients drives the global market growth

The number of patients worldwide suffering from type 1 and type 2 diabetes has grown exponentially over the last couple of years. The changing stationary lifestyle, poor eating habits, and genetic disorders are the leading cause of growth in diabetic patients. This rising insulin dependency is expected to propel the global blood glucose monitoring system market toward growth in the forecast period.

In 2021, International Diabetes Federation published a report, the findings of which stated that around 537M of the population in countries like India, Mexico, and China suffer from diabetes.

The presence of multiple manufacturers of blood glucose monitoring systems offering technically advanced devices at favorable prices is anticipated to contribute to the global market growth during the forecast period.

Developed economies having state-of-the-art medical facilities are expected to fuel global market growth.

Global Blood Glucose Monitoring System MarketRequest Free Sample

Blood Glucose Monitoring System Market: Restraints

Lack of awareness along with the high cost of devices in emerging economies restrain the global market

A fair share of the population in growing economies is unaware of diabetes and its management. Furthermore, developing economies lack the necessary infrastructure for treatment facilities to manage chronic diseases like diabetes. The lack of awareness and absence of advanced medical facilities is expected to hamper the blood glucose monitoring system market during the forecast period.

Emerging economies are also lagging in the necessary funding required for R&D which restricts the global market growth.

SMBG and CGM are invasive techniques. Patients’ hesitancy while using invasive methods for tracking diabetes is projected to restrict global market growth.

Blood Glucose Monitoring System Market: Opportunities

Explosive amount of untapped market to provide growth opportunities in the global market

As per IDF's 2021 report, half of the total diabetic patients have remained undiagnosed in Africa. Around 56% of the Asia-Pacific population comprises undiagnosed patients. This provides a massive opportunity for global market leaders to tap into.

The country's governments have been taking proactive actions, conducting programs to educate the masses about diabetes and ways to control it. The global blood glucose monitoring system market can bank upon these initiatives to provide growth opportunities in the forecast period.

Blood Glucose Monitoring System Market: Challenges

Lack of funding presents a challenge for the global market growth

Lack of funding for technical advancement in the field of blood glucose monitoring systems poses a major challenge in the global market during the forecast period. Developed countries have shown more acceptance towards BGM devices owing to better awareness and technically rich devices However, developing economies need more investment to penetrate every corner of the target global market.

For developing nations, the prices of BGM devices can be relatively higher than in developed nations. The maintenance and supporting accessories increase the overall cost of the device making it less cost-effective for patients in these territories. This is a major challenge for the global market to tackle.

Diabetes is one of the few medical conditions which are not reimbursed by healthcare agencies. The absence of reimbursement, particularly in SMBG, challenges the upward global market growth. Since the disease is not reimbursed, a potential number of patients fail to get themselves tested for diabetes and a huge chunk of the global market remains in isolation.

 Blood Glucose Monitoring System Market: Segmentation

The global blood glucose monitoring system is segmented based on product, testing site, indication, end-user, and region.

Based on product, the global market is segmented between self-monitoring and continuous glucose monitoring devices. SBGM is expected to maintain the highest share in the global market owing to its cost-effectiveness and hassle-free usage.

Based on testing sites, the global market is segmented between fingertip testing and alternate site testing. Fingertip testing is anticipated to cover the market share more than alternate site testing during the forecast period.

Based on indication, the global market is segmented between type-I diabetes, type-II diabetes, and others. As of 2021, the global market share was dominated by type-II diabetic patients because of more patients suffering from type-II diabetic conditions.

Based on end-user, the global market is segmented by hospitals, clinics, and home care. In 2021, the hospital segment marked the highest revenue and is anticipated to lead the global market during the forecast part owing to heavy investments in the hospital segment.

Blood Glucose Monitoring System Market Report Scope:

Report Attributes Report Details
Report Name Blood Glucose Monitoring System Market Research Report
Market Size in 2021 USD 14.79 Billion
Market Forecast in 2028 USD 31.5 Billion
Compound Annual Growth Rate CAGR of 10.12%
Number of Pages 205
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Glysens Incorporated, Lifescan IP Holdings, Senseonics, Prodigy Diabetes Care, B. Braun Melsungen AG, Terumo Corporation, ACON Laboratories, Medtronic, F.Hoffmann-la Roche, Sanofi, Dexcom Inc, Novo Nordisk, Insulet Corporation, Ascensia Diabetes Care, Ypsomed Holdings, Nova Biomedical.
Segments Covered By Product, By Distribution Channel, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Countries Covered North America: U.S and Canada
Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Chile
The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2021
Historical Year 2016 to 2020
Forecast Year 2022 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

 

Recent Developments:

  • In January 2022, a non-invasive blood glucose testing prototype was invented by Scanbo, that provides blood glucose results in 60 secs. This invention will help cater to diabetic patients who are less comfortable with invasive blood glucose testing methods.
  • In March 2021, Omron Healthcare Inc. announced its expansion plans in India in the year 2021. Omron is a health device manufacturing company and its intention is to increase BGM device retails by 35 to 40%, in India.

Blood Glucose Monitoring System Market: Regional landscape

The global market is likely to be led by North America during the forecast period

North America was attributed with the highest global blood glucose monitoring system market in 2021 owing to a 35.5% share of the global revenue. Prevalence of obesity in addition to the high standard of medical assistance provided to patients, technically advanced equipment is expected to assist North America in staying the highest revenue contributor during the forecast period.

Europe shares a significant amount of global market share because of the awareness and proactive approach of its population in diagnosing and managing diabetes. Europe is expected to continue its growth streak because of the intense investment in healthcare facilities.

Asia Pacific is anticipated to register a higher CAGR during the forecast period owing to growing awareness & acceptance of BGM systems, particularly in India & China. The increase in investments in medical facilities is also a major cause of the anticipated growth. The slow but steady growth in the spending capability of the general population is another factor expected to contribute to the global market.

The Middle East, Latin America & Africa are expected to show slow growth majorly because of a lack of awareness amongst the population about proper diabetes management. The number of undiagnosed patients in these regions still remains high causing a lagging growth graph in the global market. Below-par standard of living is also one of the causes of registering slower CAGR.

Blood Glucose Monitoring System Market: Competitive Analysis

The global blood glucose monitoring system market is dominated by leaders like

  • Glysens Incorporated
  • Lifescan IP Holdings
  • Senseonics
  • Prodigy Diabetes Care
  • B. Braun Melsungen AG
  • Terumo Corporation
  • ACON Laboratories,  Medtronic
  • F.Hoffmann-la Roche
  • Sanofi
  • Dexcom Inc
  • Novo Nordisk
  • Insulet Corporation
  • Ascensia Diabetes Care
  • Ypsomed Holdings
  • Nova Biomedical.

The global blood glucose monitoring system market is segmented as follows:

By Product:

  • Self-monitoring system
  • Continuous glucose monitoring system

By Testing Site:

  • Fingertip testing
  • Alternate site testing

By Indication:

  • Type-I diabetes
  • Type-II diabetes
  • Others

By End-User

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of The Middle East & Africa

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

The number of patients worldwide suffering from type 1 and type 2 diabetes has grown exponentially over the last couple of years. This rising insulin dependency is expected to propel the global market towards growth in the forecast period. The presence of multiple manufacturers of blood glucose monitoring systems offering technically advanced devices at favorable prices is anticipated to contribute to the global market growth during the forecast period. The developed economies having state-of-the-art medical facilities are expected to fuel the global market.

According to Zion Market Research, the global blood glucose monitoring system was at a net worth of $14.79B in 2021 and is projected to grow at a CAGR of 10.12% between 2022-2028 & reach a market value of $31.5B during the forecast period

North America was attributed with the highest global blood glucose monitoring system market in 2021 owing to a 35.5% share of the global revenue. It is expected to follow the growing trend during the forecast period. North America is followed by Europe owing to the awareness and proactive approach of their population in diagnosing and managing diabetes Asia-Pacific is anticipated to register a higher CAGR during the forecast period because of rising acceptance of BGM devices and growing standard of living. The Middle East, Latin America & Africa are expected to show steady growth majorly because of a lack of awareness amongst the population about proper diabetes management.

The global blood glucose monitoring system market is dominated by leaders like Glysens Incorporated, Lifescan IP Holdings, Senseonics, Prodigy Diabetes Care, B. Braun Melsungen AG, Terumo Corporation, ACON Laboratories,  Medtronic, F.Hoffmann-la Roche, Sanofi, Dexcom Inc, Novo Nordisk, Insulet Corporation, Ascensia Diabetes Care, Ypsomed Holdings, Nova Biomedical.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed